Understanding Nmosd Current And Emerging Treatment Options
Welcome to our comprehensive guide on Nmosd Current And Emerging Treatment Options. Presentation lead by Dr. Irena Dujmovic, Department of Neurology at UNC Chapel Hill.
Key Takeaways about Nmosd Current And Emerging Treatment Options
- Presentation lead by Dr. Donna Graves, Atrium Health.
- Michael Levy, MD, PhD, Massachusetts General Hospital and Harvard Medical School, Boston, MA, discusses factors influencing ...
- Michael Levy, MD, PhD, Massachusetts General Hospital and Harvard Medical School, Boston, MA, describes the substantial ...
- Cara Amos of Alexion, AstraZeneca Rare Disease provided an overview of Soliris, an FDA-approved
- In the auspices of Emirates Sclerosis Education and Neuro Series, a live webinar was organized on the topic “
Detailed Analysis of Nmosd Current And Emerging Treatment Options
Dalia Rotstein, MD, MPH, St. Michael's Hospital and the University of Toronto, Toronto, ON, gives an overview of the Brian Weinshenker, MD, presents his lecture titled "Neuromyelitis Optica Spectrum Disorders: Neuromyelitis Optica Spectrum Disorders:
Kazuo Fujihara, MD, PhD, Fukushima Medical University School of Medicine, Fukushima, Japan, outlines the revised diagnostic ...
In summary, understanding Nmosd Current And Emerging Treatment Options gives us a better perspective.
